Article
Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer.
Oncogene - 1 Sept 2005
Cinti Caterina, Macaluso Marcella, Giordano Antonio
Abstract excerpt
Genetic alterations in Rb2/p130 gene have been reported in several tumors, but till now there are insufficient and conflicting data linking the loss of pRb2/p130 expression with the mutational status of this gene in lung cancer. We recently reported that loss or lowering of pRb2/p130 expression is mainly due to aberrant Rb2/p130 promoter methylation, in retinoblastoma tumors, and indicated that epigenetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
